Fulminant SSPE Presenting as a Hyperkinetic Movement Disorder
Sign Up to like & getrecommendations! Published in 2023 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13686
Abstract: Fulminant SSPE (Subacute Sclerosing Panencephalitis) has been de fi ned as the development of at least 66% neurological disability within 3 months of the fi rst neurological symptom and death or a severe neurological disability… read more here.
Keywords: movement; hyperkinetic movement; sspe; fulminant sspe ... See more keywords
Subacute Sclerosing Panencephalitis (SSPE): Experience from a Tertiary-Care Pediatric Center
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neurosciences in Rural Practice"
DOI: 10.1055/s-0041-1740612
Abstract: Introduction Subacute sclerosing panencephalitis (SSPE) is a devastating neurodegenerative disease occurring as a complication of measles infection that is still prevalent in low-resource countries. Clinical and electrographical variability in SSPE can lead to diagnostic delays.… read more here.
Keywords: subacute sclerosing; tertiary care; panencephalitis sspe; sclerosing panencephalitis ... See more keywords
Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Virology"
DOI: 10.1128/jvi.01874-23
Abstract: ABSTRACT Subacute sclerosing panencephalitis (SSPE) is a rare but fatal late neurological complication of measles, caused by persistent measles virus (MeV) infection of the central nervous system. There are no drugs approved for the treatment… read more here.
Keywords: treatment; mev; brain; sspe ... See more keywords